Inhibition of inflammation by a p38 MAP kinase targeted cell permeable peptide

Medicinal Chemistry

Volumn 4, Issue 6, 2008, Pages 597-604

  Fu, Jing ^a,b   Meng, Xianmei ^a   He, Junyun ^a   Gu, Jun ^a  

^a PEKING UNIVERSITY   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; INDOMETACIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE DERIVATIVE; TAT MITOGEN ACTIVATED PROTEIN KINASE KINASE 3B; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DOWNSTREAM PROCESSING; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG SYNTHESIS; EDEMA; MALE; MOLECULAR DOCKING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CELL MEMBRANE PERMEABILITY; EDEMA; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE PRODUCTS, TAT; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MAP KINASE KINASE 3; MICE; MICE, INBRED BALB C; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; RECOMBINANT FUSION PROTEINS; SURFACE PLASMON RESONANCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57349142515     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340608786242106     Document Type: Article

References (26)

1. Cowan, K.J.; Storey, K.B. J. Exp. Biol., 2003, 206, 1107-15.
2. Johnson, G.L.; Lapadat, R. Science, 2002, 298, 1911-2.
3. Lee, J,C.; Laydon, J.T.; McDonnell, P.C.; Gallagher, T.F.; Kumar, S.; Green, D.; McNulty, D.; Blumenthal, M.J.; Heys, J.R.; Landvatter, S.W. Nature, 1994, 372, 739-46.
4. Kumar, S.; Boehm, J.; Lee, J.C. Nat. Rev. Drug Discov., 2003, 2, 717-26.
5. Dominguez, C.; Powers, D.A.; Tamayo, N. Curr. Opin. Drug Discov. Devel., 2005, 8, 421-30.
6. Schieven, G.L. Curr. Top Med. Chem., 2005, 5, 921-8.
7. Van Deventer, S.J. Gut 50 Suppl., 2002, 3, III47-53.
8. Lee, M.R.; Dominguez, C. Curr. Med. Chem., 2005, 12, 2979-94.
9. Adams, J.L.; Boehm, J.C.; Kassis, S.; Gorycki, P.D.; Webb, E.F.; Hall, R.; Sorenson, M.; Lee, J.C.; Ayrton, A.; Griswold, D.E.; Gallagher, T.F. Bioorg. Med. Chem. Lett., 1998, 8, 3111-6.
10. Argast, G.M.; Fausto, N.; Campbell, J.S. Mol. Cell Biochem., 2005, 268, 129-40.
11. Laufer, S.A.; Margutti, S.; Fritz, M.D. Chem. Med. Chem., 2006, 1, 97-207.
12. Morel, C.; Ibarz, G.; Oiry, C.; Carnazzi, E.; Berge, G.; Gagne, D.; Galleyrand, J.C.; Martinez, J. J. Biol. Chem., 2005, 280, 21384-93.
13. Ono, K.; Han, J. Cell Signal, 2000, 12, 1-13.
14. Chang, C.I.; Xu, B.E.; Akella, R.; Cobb, M.H.; Goldsmith, E.J. Mol. Cell, 2002, 9, 1241-9.
15. Enslen, H.; Davis, R.J. Biol. Cell 2001, 93, 5-14.
16. Tanoue, T.; Adachi, M.; Moriguchi, T.; Nishida, E. Nat. Cell Biol., 2000, 2, 110-6.
17. Barr, R.K.; Kendrick, T.S.; Bogoyevitch, M.A. J. Biol. Chem., 2002, 277, 10987-97.
18. Bonny, C.; Oberson, A.; Negri, S.; Sauser, C.; Schorderet, D.F. Diabetes, 2001, 50, 77-82.
19. Kelemen, B.R; Hsiao, K.; Goueli, S.A. J. Biol. Chem., 2002, 277, 8741-8.
20. Fu, J.; Yang, Z.; Wei. J.; Han, J.; Gu, J. J. Cell Sci., 2006, 119, 115-23.
21. Underwood, D.C.; Osborn, R.R.; Kotzer, C.J.; Adams, J.L.; Lee, J.C.; Webb, E.F.; Carpenter, D.C.; Bochnowicz, S.; Thomas, H.C.; Hay, D.W.; Griswold, D.E. J. Pharmacol Exp. Ther., 2000, 293, 281-8.
22. Ho, D.T.; Bardwell, A.J.; Abdollahi, M.; Bardwell, L. J. Biol. Chem., 2003, 278, 32662-72.
23. Kuma, Y.; Sabio, G.; Bain, J.; Shpiro, N.; Marquez, R.; Cuenda, A. J. Biol. Chem., 2005, 280, 19472-9.
24. Joliot, A.; Prochiantz, A. Nat. Cell Biol., 2004, 6, 189-96.
25. Hosseinzadeh, H.; Ramezani, M.; Salmani, G.A. J. Ethnopharmacol., 2000, 73, 379-85.
26. Sambrook, J.; Fritch, E.F.; Maniatis, T. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press 1989.